Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial

Melanie B. Gillingham, Stephen B. Heitner, Julie Martin, Sarah Rose, Amy Goldstein, Areeg Hassan El-Gharbawy, Stephanie Deward, Michael R. Lasarev, Jim Pollaro, James P. DeLany, Luke J. Burchill, Bret Goodpaster, James Shoemaker, Dietrich Matern, Cary O. Harding, Jerry Vockley

Research output: Contribution to journalArticlepeer-review

75 Scopus citations

Fingerprint

Dive into the research topics of 'Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences